Spots Global Cancer Trial Database for Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.

Official Title: Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis

Study ID: NCT04792138

Conditions

Prostate Cancer

Prostate Neoplasm

Interventions

VERDICT MRI

Luminal Index Imaging

Study Description

Brief Summary: Multiparametric magnetic resonance imaging (mpMRI) is now widely used to risk stratify men with a suspicion of prostate cancer and identify suspicious regions for biopsy. Advanced MRI techniques have emerged which seek to improve this characterisation and could predict biopsy results non-invasively before men undergo biopsy. Before these techniques are translated clinically, robust histological and clinical validation is required. This study aims to clinically validate advanced MRI techniques in a cohort of men suspected with prostate cancer. Histological analysis of men undergoing biopsy, +/- prostatectomy will be used for biological validation of VERDICT; Vascular and Extracellular Restricted Diffusion for Cytometry in Tumours and Luminal Water imaging (LWI). In particular, prostatectomy specimens will be processed using 3-D printed patient-specific moulds to allow for accurate MRI and histology mapping.

Detailed Description: